Follow the 큐리옥스바이오시스템즈 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 큐리옥스바이오시스템즈 has logged 49 public disclosures. Market capitalisation: €705.3bn. The latest transaction was reported on 7 August 2026 (Purchase). Among the most active insiders: 김남용. All data is accessible without an account.
47
Insider Decl.
n/a
Thresholds
€221,840
30 ops.
Buy Volume
€3m
4 ops.
Sell Volume
31Σ signal
Buys €221,840€3m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.